Our Mission

Provide best in class consulting in reimbursement, regulatory affairs, and clinical to biomedical companies, globally.

Just ask our clients

We customize solutions that fit the needs of needs of all our clients, and strive to ensure the success of each and every one of them

Learn how TAMM Net can help your medical miracle blossom

Quality & Regulatory

TAMM Net develops the regulatory strategy, filings, and compliance auditing that will get you on the right path.

Learn More

Managed Markets & Reimbursement

Analysis, planning, execution, coding, payer assessments... Everything you need to manage managed markets.

Learn More

Reimbursement Support Call Center Activities

Prior authorizations, reimbursement guides, verification, and sales force support are just some of our offerings.

Learn More


We won't only help you develop a clinical plan, we'll even integrate it with regulatory and reimbursement requirements.

TAMM Net Services Flyer

See Our Services Flyer

English Deutsch Italiano

Our Process Ensures Predictable Outcomes

A multi-step process ensures we learn all we can about your needs and provide consistent, high-quality product.

Discovery and Requirements

8-12 step process.

It is vital to take the time and effort required to completely capture the knowledge you have about your product and therapeutic area. Asking the right questions at this stage is critical for helping to prevent needless expenditures and inefficiencies.

When we perform claims analysis there are many different databases from which to collect claims data. By asking our clients detailed questions about the purpose of the analysis and their knowledge of where the procedures are performed and by whom, we can propose the most appropriate resources.

Planning (GAP Analysis)

11-18 step process

For a recent cellular therapy client, performing a gap analysis was critical in their initial fundraising. By identifying exactly what additional information was needed to obtain an IND, they presented successfully to investors.


Reimbursement is its own strategic morass. By creating an overall portfolio clinical development plan, we can anticipate any resistance that may be brought by medical societies or payers. For a client in a very competitive space with huge existing competition, this enabled us to plan a sequential new coding strategy to minimize resistance.

Implementation & Execution (Clinical Development Plan)

9 step process

A carefully laid plan leads to a systematic execution and the ability to adapt when regulatory bodies change their minds. Our internal processes ensure that execution is both accurate and timely.


9-18 step process

Delivery is another dialogue. We typically deliver a draft to ensure that we are capturing everything in the statement of work. Once all parties agree on the draft final versions are produced.

“TAMM Net has been a valuable partner helping us navigate reimbursement and regulatory. They coordinated our activities with CMS including a successful C-code application and connected us with policy representatives in medical societies. TAMM Net’s regulatory team efficiently wrote and submitted our successful 510(k) application for CivaSheet. They have helped our company meet key milestones. We continue to work with TAMM Net because of the professionalism and effectiveness they bring to each task.” —Susan Babcock

Close & Continuation

6-8 step process

We engage with our clients early in the development process and stay connected after any project is done. For most of our clients, our engagement is an ongoing partnership. We want to make sure that if there are any questions about our work, we are there to answer them as they arise. Of course, this also leads to many referrals, for which we are grateful.

Our Values

Our values are a reflection of the work we do for you.

Grateful to our clients and colleagues
Reliable in our deeds and actions
Accountable to all
Unwavering Integrity
Long-term Outlook

Leadership Team

TAMM Net is led by a world-class team of experienced biomedical professionals

Arthur F. Spalding

Arthur F. Spalding


Mr. Spalding has over 20 years’ experience in pharmaceuticals and medical devices directing various functions including: reimbursement, clinical trial design and facility recruitment, distribution, business development, managed markets, market research, hospital sales, forecasting, and sales operations. Mr. Spalding held management and director level positions at various companies including Parke-Davis, Pfizer, Solvay, Peer-Point Medical Education, and Columbia Laboratories.In 2009, Mr. Spalding started TAMM Net, Inc., a consultancy servicing biomedical manufacturers. TAMM Net has helped manufacturers: conduct clinical trials using federal resources; gain reimbursement; gain marketing approvals/clearances; and sell to federal purchasers. Mr. Spalding holds a B.S. in Chemistry from Union College, Schenectady, NY and an MBA in Health Administration from Temple University in Philadelphia.

Janan VanOsdell

Janan Van Osdell, MBA, MHSA

Director, Clinical Research

Ms. Van Osdell has over 25 years’ experience in various aspects of health care and the pharmaceutical industry resulting in a unique blend of business and science. Her primary responsibilities are clinical research projects. She is an excellent medical writer of both clinical and regulatory documents. She develops and coordinates professional education and training events to support clinical research staff and training on new technologies and procedures. Before joining TAMM Net, she managed Continuing Medical Education department at Solvay Pharmaceuticals, Inc. where she was responsible for regulatory compliance, processes, budgeting, and grant review. Her career includes 15 years with Procter & Gamble Pharmaceuticals where she worked in Clinical Research, Professional Relations, Health Economics, and Educational Marketing. Her achievements at Procter & Gamble Pharmaceuticals include clinical research trial manager for bringing naproxyn sodium from RX to OTC as the branded OTC analgesic, Aleve®; and she worked seven years with inflammatory bowel disease physicians and patients with the branded mesalamine, Asacol®. Prior to Procter & Gamble Pharmaceuticals, she was a research dental hygienist and managed the Periodontal Dental Research Clinic at Emory University. Ms. Van Osdell earned both MBA and MHSA (Health Services Administration) degrees from Xavier University in Cincinnati, Ohio. Her bachelor degree in Dental Hygiene is from the LSU Health Sciences Center in New Orleans, LA. She also completed accounting and finance studies and is a Certified Public Accountant.

Sue Beth Murphree

Sue Beth Murphree MPH, NMT

Director Strategic Payer Management

Ms. Murphree has over 20 years in the healthcare field including demonstrated experience in gaining coverage decisions and Influencing development of favorable coverage policies for medical devices. Her expertise includes medical device reimbursement, market access, policy development, managed markets negotiation, business development, high tech clinical experience. Ms. Murphree has enjoyed developing specific Orthopedic reimbursement opportunities to come to completion in multiple national medical device companies such as Smith & Nephew, Arthrex and multiple start-up companies such as St. Francis Medical technologies and SI Bone. She has significant experience in establishing coverage policies with government and commercial payors, as well as new reimbursement code processes. Other experience in managing large territories with numerous accounts, negotiates contracts, and devise and deliver marketing campaigns to healthcare professionals. Ms. Murphree joined TAMM Net in 2018. Ms. Murphree earned both MPH and NMT degrees from University of Alabama at Birmingham.

Srinagesh Koushik PhD RAC

Srinagesh Koushik PhD RAC

Regulatory and Quality System Consultant

Regulatory affairs and business development professional with strong interpersonal skills and drive to cultivate manage and mentor relationships. Experienced in developing regulatory compliance strategies and delegating responsibilities to team members. Excellent project manager with extensive experience in maintaining pre and post market FDA regulatory compliance, including authoring premarket marketing applications, pre marketing meeting requests, meeting coordination, responding to FDA requests, conducting internal audits, creating and maintaining quality systems and manufacturing documentation for clients. Experienced with handling changing priorities in the regulatory and business development landscape and am adept at analyzing and developing responses to assist in successful completion of the project. Successfully submitted multiple pre market and post market submissions to the FDA. Extensive network within the industry and at the FDA, whose expertise I leverage, when navigating confounding drug, device and cosmetic regulations.

Betty Lou Anderson

Betty Lou Anderson

Director of Business Development

Mrs. Anderson brings over 20' years of US healthcare sales experience years to TAMM Net. She has a depth of experience working in a variety of non-clinical and clinical sales roles within pharmaceutical and biotech companies, hospitals, physician practices, and health systems. These roles have included working closely with specialty physicians, mid-levels, scientists, pathologists, laboratory and hospital personnel, pharmacists and C-level executives. Her experience as a Business Development professional encompasses collaborating with healthcare professionals across many different disease states. Throughout her career, Mrs. Anderson was recognized with President's Club for outstanding business results, and mentorship. Her most recent professional experience has been working with the world's largest Contract Research Organization, Covance, a division of LabCorp. Prior to this role, she was a Brand Ambassador in Strategic Accounts for Jackson Healthcare, and she has a breadth of knowledge in Women's Health where she spent a large portion of her sales career with Wyeth Pharmaceutical company. Mrs. Anderson holds a B.S. in Communication Arts from Georgia Southern University.

Jennifer Short

Jennifer Short, RN

Regional Director, Clinical Research

Ms. Short has 14 years’ experience in medical device distribution in the Orthopedic and OBGYN marketplace, as well as in the dental Cad/Cam industry. Ms. Short has worked her way up the sales ladder, from associate to national sales manager. Ms. Short has built her own businesses and helped small companies pioneer new devices and procedures. Ms. Short is a lead by example sales manager, who has proved to be successful at any level. Ms. Short has a Master’s Certificate from UCI for Medical Product Development, and obtained a B.S. in Exercise & Sport Science-Sports Medicine Concentration from Colorado State Universit

Charles Smeltzer

Charles Smeltzer

Director of IT

Mr. Smeltzer has over 10 years experience in big data processing and analytics. He supports innovative software development in a number ways: efficient query design [MySQL, PostGRE], interactive software design [GTK], web design [Javascript, HTML5], microsensors and XML phrasing. He is an experienced research associate from the Georgia Institute of Technology and holds a masters in atmospheric science with focus on improving satellite retrieval algorithms and numerical model simulations of the atmosphere. He taught a course statistical analysis [MATLAB, R]. Mr. Smeltzer sits on the NASA GES DISC board, the largest distributor of Earth science data in the world. Before coming to TAMM Net, Mr. Smeltzer developed software for Airborne Research Consultants, Institute for Airborne Research, Xerxzed Inc., and Blend Logic LLC. POC: NOAA is the largest distributor of operational weather forecasting data.

Kirk Van Ness

Kirk Van Ness

Kirk Van Ness, PhD, DABT, has more than 25 years of drug development experience with both small molecules and biotherapeutics. He brings a strong preclinical development regulatory background in toxicology coupled with expertise in mechanistic toxicology focused on renal-, hepatic- and immunotoxicology. He is capable of designing, implementing and finalizing a broad range of nonclinical safety assessment studies for biopharmaceuticals (recombinant cytokines, mAbs, Fc-fusion proteins), small molecules, anti-sense RNA therapeutics, nanoparticle drug delivery systems and medical devices.

Kirk has comprehensive knowledge of the nonclinical development regulatory requirements necessary to advance successful drug candidates through the pipeline. He has worked with small and large drug development companies to guide nonclinical study designs in support of all phases of clinical development and has assisted with FDA interactions and adherence to FDA-ICH guidelines. As an integral member of drug development teams at Amgen (and previously at Immunex), ZymoGenetics and Sarepta (formerly AVI BioPharma) he has experience working with pharmacokinetic, regulatory, clinical, research and manufacturing colleagues to ensure on time quality deliverables. Kirk is a board-certified toxicologist (Diplomate of the American Board of Toxicology) since 2009.

Pamela McColl

Pamela McColl

Mrs. McColl has over 15 years working in regulated industries including banking, medical devices, and biologics. Her technical expertise includes FDA, ISO 13485, Notified body, American Association Tissue Banking, ISO 13485 Auditor for a Registrar, and various other international audits. She has written numerous Medical Device Quality Systems from beginning to end for ISO Certification. Assisted companies in providing their internal audit, providing gap analysis for QMS as well as reviewing, revising their Quality System to be audited by a notified body for ISO Certification. Well over 100 audits (including international audits) of suppliers, manufacturers, ISO, sterilizers, and tissue recovery organizations combined. As a compliance auditor at CryoLife she became an expert at good tissue practices while performing internal and supplier audits, and meeting many other corporate objectives. She has participated in several FDA audits and assisted in alleviating warning letters. She directed multiple corrective action and preventive action (CAPA) programs.

Jeffrey P. Bush

Jeffrey P. Bush, CT (ASCP), MBA

With over 30 years of experience in diagnostic, medical device and clinical laboratory industries, Jeff Bush applies his expertise to the development and implementation of market access and business development strategies as they intersect at the point of healthcare product commercialization. He has a proven track record as a leader across the industry managing substantial portfolios within start-up, mid-sized, and Fortune 200 companies.

Jeff served as Vice President, Business Development at Genetesis. Prior to Genetesis, Jeff was Vice President, Payer Markets and Reimbursement at Assurex Health. During his tenure, he led the company to coverage and payment by Medicare and other payers fueling the company's rapid growth from <$10M per year revenue to nearly $120M per year trajectory over 4 years (>86% CAGR). Jeff was a key member of the Assurex executive leadership team, and he also held responsibility for the company's health economic analysis development plan leading to an AJMC cost-effectiveness publication. Prior to Assurex, Jeff was the Worldwide Director of Corporate Reimbursement for Becton, Dickinson and Company (BD) where he was responsible for building the company’s worldwide function focused on coding, coverage, and payment for the company’s products in the United States and overseas. Jeff represented BD within the AdvaMed trade association Board Payment Committee, was a well-recognized leader within the organization, and twice chaired the Diagnostics Payment Working Group (DPWG), including development and oversight for the landmark “Value of Diagnostics” report commissioned by the association in 2005.

Jeff earned a Bachelor’s degree in Chemistry from California State University, a certificate in Cytotechnology from Loma Linda University and an MBA from Colorado State University.

Contact Us




Area of Interest:
Quality & Regulatory
Managed Markets & Reimbursement
Reimbursement Support Call Center Activities
Research & Clinical Plan


Alternatively, Email us at info@tammnet.com

Our Affiliates